Patients with active disease not comprising any vascular involvement (V.I.) and patients with active vascular involvement in SLE showed a trend toward higher PTX3 levels compared to patients with clinically quiescent disease.
← all excerpts
PTX3 Intercepts Vascular Inflammation in Systemic Immune-Mediated Diseases.
1
—
—